The product is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Bondlido ® (lidocaine topical system 10%) for the relief of pain associated with ...

In the study, "A randomized, double-blind, placebo-controlled phase 1 trial of the topical pan-lysyl oxidase inhibitor PXS-6302 in mature scars," published in Science Translational Medicine, ...

In early clinical research, a novel topical agent under development for androgenetic alopecia (AGA) delivered hair density increases greater than 20% for about one third of patients with a higher ...

Your dog wants nothing to do with fleas because they’d make her itch. What she’s unaware of is that these narrow-bodied little broad jumpers can carry tapeworms and plague. She doesn’t want ticks ...

The U.S. Food and Drug Administration has approved a new shot that protects dogs six months or older against fleas and ticks. Merck Animal Health's Bravecto Quantum is officially the first FDA ...

Bravecto Quantum becomes first FDA approved drug to protect dogs against fleas and ticks for 8 to 12 months. Bravecto Quantum is the first FDA-approved drug that treats and prevents flea and tick ...

Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, New Jersey, USA, announced the US Food and Drug Administration (FDA) ...

Bravecto Quantum, a breakthrough, long-acting flea and tick treatment and preventative for dogs, will be available soon. Made by Merck Animal Health, the once-yearly shot can protect dogs for up to 12 ...

12-Month Parasiticide Treatment for Dogs Offers Unrivaled Duration of Flea and Tick Protection Compared to Existing Products BRAVECTO QUANTUM was first approved in Australia and New Zealand in 2023, ...